BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9656422)

  • 1. Analyses of leucocytes in blood and lymphoid tissues from mink infected with Aleutian mink disease parvovirus (AMDV).
    Chen W; Aasted B
    Vet Immunol Immunopathol; 1998 Jun; 63(4):317-34. PubMed ID: 9656422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of Aleutian mink disease parvovirus virion protein VP1 and 2.
    Costello F; Steenfos N; Jensen KT; Christensen J; Gottschalck E; Holm A; Aasted B
    Scand J Immunol; 1999 Apr; 49(4):347-54. PubMed ID: 10219758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a novel B-cell epitope on Aleutian Mink Disease virus capsid protein VP2 using a monoclonal antibody.
    Lu T; Wang Y; Ge J; Ma Q; Yan W; Zhang Y; Zhao L; Chen H
    Virus Res; 2018 Mar; 248():74-79. PubMed ID: 29278728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response of black American mink to Aleutian mink disease virus.
    Farid AH; Hussain I
    Immun Inflamm Dis; 2020 Jun; 8(2):150-164. PubMed ID: 32167659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of enzyme-linked immunosorbent assays for quantification of antibodies against Aleutian mink disease virus.
    Farid AH; Rupasinghe PP
    J Virol Methods; 2016 Sep; 235():144-151. PubMed ID: 27283885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antibody production and viremia in American mink (Neovison vison) challenged with Aleutian mink disease virus.
    Farid AH; Hussain I; Rupasinghe PP; Stephen J; Arju I
    BMC Vet Res; 2022 Oct; 18(1):364. PubMed ID: 36192746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease.
    Aasted B; Alexandersen S; Christensen J
    Vaccine; 1998 Jul; 16(11-12):1158-65. PubMed ID: 9682374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Aleutian mink disease virus through high temperature exposure in vitro and under field-based composting conditions.
    Hussain I; Price GW; Farid AH
    Vet Microbiol; 2014 Sep; 173(1-2):50-8. PubMed ID: 25139658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Aleutian mink disease virus DNA and antiviral antibodies in American mink (Neovison vison) 10 days postinoculation.
    Farid AH; Hussain I; Arju I
    J Vet Diagn Invest; 2015 May; 27(3):287-94. PubMed ID: 25862712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a valine residue at codon 352 of the VP2 capsid protein on in vivo replication and pathogenesis of Aleutian disease parvovirus in mink.
    Stevenson MA; Fox JM; Wolfinbarger JB; Bloom ME
    Am J Vet Res; 2001 Oct; 62(10):1658-63. PubMed ID: 11592336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring chronic infection with a field strain of Aleutian mink disease virus.
    Jensen TH; Hammer AS; Chriél M
    Vet Microbiol; 2014 Jan; 168(2-4):420-7. PubMed ID: 24389253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel Aleutian mink disease virus B-cell epitope using a monoclonal antibody against VP2 protein.
    Yi L; Cheng Y; Zhang M; Cao Z; Tong M; Cheng S; Yan X
    Virus Res; 2016 Sep; 223():39-42. PubMed ID: 27354304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of new monoclonal antibodies that distinguish subsets of mink lymphoid cells.
    Miyazawa M; Mori S; Spangrude GJ; Wolfinbarger JB; Bloom ME
    Hybridoma; 1994 Apr; 13(2):107-14. PubMed ID: 8050775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aleutian mink disease virus and humans.
    Jepsen JR; d'Amore F; Baandrup U; Clausen MR; Gottschalck E; Aasted B
    Emerg Infect Dis; 2009 Dec; 15(12):2040-2. PubMed ID: 19961696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mink infected with Aleutian disease virus have an elevated level of CD8-positive T-lymphocytes.
    Aasted B
    Vet Immunol Immunopathol; 1989 Mar; 20(4):375-85. PubMed ID: 2785727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aleutian mink disease virus in free-ranging mink from Sweden.
    Persson S; Jensen TH; Blomström AL; Appelberg MT; Magnusson U
    PLoS One; 2015; 10(3):e0122194. PubMed ID: 25822750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of experimental chronic Aleutian mink disease virus infection.
    Jensen TH; Chriél M; Hansen MS
    Acta Vet Scand; 2016 Jun; 58(1):35. PubMed ID: 27250118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of Aleutian mink disease parvovirus in mink lymph node histocultures.
    Jensen KT; Wolfinbarger JB; Aasted B; Bloom ME
    J Gen Virol; 2000 Feb; 81(Pt 2):335-43. PubMed ID: 10644831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMDV Vaccine: Challenges and Perspectives.
    Markarian NM; Abrahamyan L
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Immunogenicity Analysis of Whole-Gene Mutation DNA Vaccine of Aleutian Mink Virus Isolated Virulent Strain.
    Liu D; Li J; Shi K; Zeng F; Zong Y; Leng X; Lu H; Du R
    Viral Immunol; 2018; 31(1):69-77. PubMed ID: 28829241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.